NCT04908644View on ClinicalTrials.gov

MS-20 on Patients With Ulcerative Colitis(UC)

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 18, 2021

Primary Completion Date

November 30, 2024

Study Completion Date

November 30, 2024

Conditions
Ulcerative Colitis
Interventions
DRUG

MS-20 oral solution

Fermented soybean extract MicrSoy-20(MS-20), which uses a variety of lactic acid bacteria and yeasts to metabolize organic soybeans

OTHER

Placebo

Placebo

Trial Locations (1)

100

RECRUITING

National Taiwan University Hospital, Taipei

All Listed Sponsors
collaborator

Microbio Co Ltd

INDUSTRY

lead

National Taiwan University Hospital

OTHER